Modulation of the IL-10/IL-12 cytokine circuit by interferon-β inhibits the development of epitope spreading and disease progression in murine autoimmune encephalomyelitis

Journal of Neuroimmunology

Volumn 111, Issue 1-2, 2000, Pages 55-63

  Tuohy, Vincent K ^a   Yu, Min ^a   Yin, Ling ^a   Mathisen, Peter M ^a   Johnson, Justin M ^a   Kawczak, Julie A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Autoimmunity; Cytokines; EAE MS; T Lymphocytes; Th1 Th2

Indexed keywords

BETA INTERFERON; CYTOKINE; ELISARTAN; EPITOPE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; MYELIN BASIC PROTEIN; PROTEOLIPID PROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; FEMALE; HELPER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL;

ADJUVANTS, IMMUNOLOGIC; ANIMAL; DISEASE PROGRESSION; ENCEPHALOMYELITIS, EXPERIMENTAL AUTOIMMUNE; EPITOPES, T-LYMPHOCYTE; FEMALE; IMMUNIZATION; INTERFERON-BETA; INTERLEUKIN-10; INTERLEUKIN-12; MICE; MICE, INBRED STRAINS; MYELIN PROTEOLIPID PROTEIN; PEPTIDE FRAGMENTS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TH1 CELLS; TH2 CELLS;

EID: 0034332949     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(00)00384-2     Document Type: Article

References (54)

1. Functional diversity of helper T lymphocytes
2. Interferon in experimental autoimmune encephalomyelitis (EAE): effects of exogenous interferon on the antigen-enhanced adoptive transfer of EAE
3. Immunologic therapy of multiple sclerosis
4. Natural killer cells in antiviral defense: function and regulation by innate cytokines
5. Interferons: pleiotropic cellular modulators
6. + T cells
7. Interferon-beta 1b treatment decreases tumor necrosis factor-alpha and increases interleukin-6 production in multiple sclerosis
8. VLA-4 expression on peripheral blood lymphocytes is downregulated after treatment of multiple sclerosis with interferon beta
9. Reduction of transendothelial migration of mononuclear cells in interferon-beta1b-treated multiple sclerosis patients [letter]
10. Two roads diverged: interferon alpha/beta- and interleukin 12-mediated pathways in promoting T cell interferon gamma responses during viral infection
11. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via down regulation of class II major histocompatibility complex
12. IL-10 inhibits mitogen-induced T cell proliferation by selectively inhibiting macrophage costimulatory function
13. The molecular cell biology of interferon-gamma and its receptor
14. IL-10 inhibits cytokine production by activated macrophages
15. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells
16. Interferons
17. Do effector and memory T helper cells also need B7 ligand costimulatory signals?
18. Interferon induces peripheral lymphadenopathy in mice
19. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis
20. A phase III trial of intramuscular recombinant interferon beta as treatment for exacerbating-remitting multiple sclerosis: design and conduct of study and baseline characteristics of patients. Multiple Sclerosis Collaborative Research Group (MSCRG)
21. Interferon β in multiple sclerosis: is IL-12 suppression the key?
22. High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10
23. Interferon production by individual cells in culture
24. Determinant spreading and the dynamics of the autoimmune T-cell repertoire
25. Interferon beta-1b inhibits gelatinase secretion and in vitro migration of human T cells: a possible mechanism for treatment efficacy in multiple sclerosis
26. Induced IL-10 production by IFNβ and its cellular sources in PBMC
27. + T cells
28. Interferon (IFN) beta acts downstream of IFN-gamma-induced class II transactivator messenger RNA accumulation to block major histocompatibility complex class II gene expression and requires the 48-kD DNA-binding protein, ISGF3-gamma
29. Polyinosinic acid: polycytidylic acid promotes T helper type 1-specific immune responses by stimulating macrophage production of interferon-alpha and interleukin-12
30. Immunological aspects of demyelinating diseases
31. Human recombinant interferon-beta influences T helper subset differentiation by regulating cytokine secretion pattern and expression of homing receptors
32. Type I IFNs inhibit human dendritic cell IL-12 production and Th1 cell development
33. IFN-β differentially regulates CD40-induced cytokine secretion by human dendritic cells
34. Interferon beta decreases T cell activation and interferon gamma production in multiple sclerosis
35. Immunomodulatory effects of interferon-beta-1b in vivo: induction of the expression of transforming growth factor-beta1 and its receptor type II
36. T cell response to myelin basic protein before and after treatment with interferon beta in multiple sclerosis
37. Influence of interferon beta-1a dose frequency on PBMC cytokine secretion and biological effect markers
38. Disease-modifying drugs for relapsing-remitting multiple sclerosis and future directions for multiple sclerosis therapeutics
39. In vitro and in vivo inhibition of mitogen-driven T-cell activation by recombinant interferon beta
40. Interferon beta induces interleukin-10 expression: relevance to multiple sclerosis
41. In vivo effects of interferon beta-1a on immunosuppressive cytokines in multiple sclerosis
42. Influenza A virus-induced IFN-alpha/beta and IL-18 synergistically enhance IFN-gamma gene expression in human T cells
43. An interleukin(IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease
44. The interferon system. A bird's eye view of its biochemistry
45. Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system
46. Interferon beta-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9
47. Interferon-beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial
48. Immunobiology of interleukin-12
49. The epitope spreading cascade during progression of experimental autoimmune encephalomyelitis and multiple sclerosis
50. Migratory behavior of lymphocytes isolated from multiple sclerosis patients: effects of interferon beta-1b therapy
51. Epitope spreading
52. Interferon beta modulates experimental autoimmune encephalomyelitis by altering the pattern of cytokine secretion
53. A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease
54. Interferon-β inhibits progression of relapsing-remitting experimental autoimmune encephalomyelitis